AI-generated analysis. Always verify with the original filing.
A year of accelerating commercial traction offset by acute liquidity constraints—revenue surged 41% driven by FemBloc's European launch, yet the company faces a going concern warning with cash runway extending only to Q3 2026.
EPS
$-0.47
Revenue
$2.3M
Net Income
-$18.6M
Gross Margin
62.0%
Gross Profit
$1.4M
free cash flow
-$19.2M
Operating Income
-$17.6M
operating margin
-767.0%